Is approving esketamine as an antidepressant for treatment resistant depression associated with recreational use and risk perception of ketamine? Results from a longitudinal and cross-sectional survey in nightlife attendees

Bibliographic Data

ID14909833
AuthorsMeryem Grabski (0000-0001-6364-5269, University College London, corresponding author), Jon Waldron (0000-0002-2094-6114, University College London), Tom P Freeman (0000-0002-5667-507X, University of Bath), Margriet van Laar (0000-0003-3977-126X, Trimbos Institute), H Valerie Curran (0000-0001-6011-6978), Valerie H Curran (0000-0001-6041-5214, University College London)
Year2022
Volume102
Pages103612
Publication date2022-04-01
Open AccessYes
TypeARTICLE
VenueInternational Journal of Drug Policy (JOURNAL)
Journal identifiersISSN: 0955-3959 • E-ISSN: 1873-4758
PublisherElsevier BV (PUBLISHER)
DOI10.1016/j.drugpo.2022.103612
PMID35151083
OpenAlexW4211182554
LanguageEN
Citations received2
References cited9

Tools

Open DOI